Portage Biotech Inc. (PRTG)

[stocktrademan]

$PTGEF recent news/filings

bullish

## source: finance.yahoo.com

Wed, 22 Apr 2015 15:00:00 GMT ~ Portage's Biohaven to begin Phase 1 study in 3Q2015 and readying for Phase 3 study start by 1Q2016

[PR Newswire] - TORONTO, April 22, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that Biohaven Pharmaceutical Holding Company Limited (Biohaven), which Portage holds 54% equity, remains on schedule to initiate a Phase 1 pharmacokinetic and biomarker study with its lead drug development candidate, BHV-0223. Biohaven plans to initiate the trial no later than 3Q2015. Biohaven has entered into an exclusive world-wide agreement with Catalent to provide its Zydis® ODT fast-dissolve formulation for BHV-0223. Without any unforeseen delays, we anticipate a robust completion of the Phase 1 study that will then enable a fully powered registrational Phase 3 study to begin in early in 2016 with results available at the end of 2016 or first part of 2017", stated Kimberly Gentile, Vice-President of Operations for Biohaven.

read full: http://finance.yahoo.com/news/portages-biohaven-begin-phase-1-150000724.html
*********************************************************

Mon, 20 Apr 2015 12:48:00 GMT ~ Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier

[PR Newswire] - Portage Pharmaceuticals Ltd. (PPL) Announces that its Proprietary Human-Derived Cell Permeable Peptide (CPP) Platform Delivers a Peptide Cargo Across the Blood Brain Barrier and that this Construct Demonstrates CNS Activity. The permeability of the blood brain barrier (BBB) in mice was studied and was transiently disrupted after endotoxin (LPS) challenge.

read full: http://finance.yahoo.com/news/portages-cpp-platform-delivers-peptide-124800856.html
*********************************************************

Thu, 16 Apr 2015 13:00:00 GMT ~ Portage to Present at Master Investor 2015 in London, UK

[PR Newswire] - TORONTO, April 16, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company" )) (OTC Market: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that the Company will be presenting at the Master Investor Show on April 25, 2015 to be held in London, UK. Portage's chairman, Dr. Gregory Bailey and Mr. James Mellon, a director of Portage, will provide an overview and an update on the key programs at its subsidiaries, Portage Pharmaceuticals Ltd. ("PPL"), and Biohaven Pharmaceuticals Holding Company Ltd. ("Biohaven"), wherein the Company holds 54% equity. The Company's presentation materials will be available at the Portage booth at the Show.

read full: http://finance.yahoo.com/news/portage-present-master-investor-2015-130000502.html
*********************************************************

Wed, 01 Apr 2015 13:00:00 GMT ~ Portage's Biohaven Announces Agreement with inVentiv Health

[PR Newswire] - Biohaven and inVentiv Health Enter into Agreement for Operational Execution of Biohaven's Lead Compound Phase 1 Clinical Trial. TORONTO, April 1, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that Biohaven Pharmaceutical Holding Company Limited (Biohaven), which Portage holds 54% equity, has entered into an agreement with inVentiv Health for the operational execution of Biohaven's first clinical trial with their lead compound (BHV-0223).

read full: http://finance.yahoo.com/news/portages-biohaven-announces-agreement-inventiv-130000047.html
*********************************************************

Tue, 24 Mar 2015 13:00:00 GMT ~ Portage's Biohaven enters into exclusive formulation agreement and global license with Catalent for lead product

[PR Newswire] - Catalent has completed prototype formulation development and is delivering drug supplies for Biohaven's lead clinical product. TORONTO, March 24, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that Biohaven Pharmaceutical Holding Company Limited (Biohaven), which Portage holds 54% equity, has entered into an exclusive world-wide agreement with Catalent Pharma Solutions (CTLT) to provide Catalent's Zydis® Orally Disintegrating Tablet (ODT) technology for Biohaven's lead drug development candidate, BHV-0223.

read full: http://finance.yahoo.com/news/portages-biohaven-enters-exclusive-formulation-130000914.html
*********************************************************

$PTGEF charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$PTGEF company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/PTGEF/company-info
Ticker: $PTGEF
OTC Market Place: OTC Pink Current
CIK code: 0001095435
Company name: Portage Biotech Inc
Company website: http://www.portagebiotech.com
Incorporated In: Virgin Islands (British)

Business Description: The Company is engaged in researching and developing pharmaceutical and biotech products through to clinical ?proof of concept? with an initial focus on unmet clinical needs and orphan drugs. Following proof of concept, the Company will look to sell or license the products to large pharmaceutical companies for further development and commercialization. The Company, through its subsidiary, holds an exclusive worldwide licence in non-oncology fields and the know-how relating to the Antennapedia protein transduction technology developed by Trojantec.Less >>

$PTGEF share structure

## source: otcmarkets.com

Market Value: $18,077,579 a/o May 15, 2015
Shares Outstanding: 180,775,790 a/o May 24, 2014
Float: 86,333,997 a/o Sep 10, 2013
Authorized Shares: Unlimited a/o May 24, 2014
Par Value: No Par Value

$PTGEF extra dd links

Company name: Portage Biotech Inc
Company website: http://www.portagebiotech.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PTGEF+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PTGEF+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PTGEF+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/news - http://finance.yahoo.com/q/h?s=PTGEF+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PTGEF/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PTGEF+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PTGEF
DTCC (dtcc.com): http://search2.dtcc.com/?q=Portage+Biotech+Inc&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Portage+Biotech+Inc
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Portage+Biotech+Inc&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.portagebiotech.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.portagebiotech.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.portagebiotech.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/PTGEF
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001095435&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=PTGEF&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PTGEF
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PTGEF+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PTGEF+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PTGEF
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PTGEF
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PTGEF+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PTGEF/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PTGEF+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PTGEF.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PTGEF
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PTGEF
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PTGEF
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PTGEF:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PTGEF
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=PTGEF



$PTGEF DD Notes ~ http://www.ddnotesmaker.com/PTGEF